RUNTANZA Trademark

Trademark Overview

On Wednesday, June 3, 2020, a trademark application was filed for RUNTANZA with the United States Patent and Trademark Office. The USPTO has given the RUNTANZA trademark a serial number of 88945639. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 9, 2023. This trademark is owned by VistaPharm, Inc.. The RUNTANZA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of hypothyroidism, thyroid hormone deficiency and thyroid cancer
runtanza

General Information

Serial Number88945639
Word MarkRUNTANZA
Filing DateWednesday, June 3, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 9, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2021

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of hypothyroidism, thyroid hormone deficiency and thyroid cancer
Translation of Words in MarkThe wording "RUNTANZA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 24, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVistaPharm, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Providence, NJ 07974
Party NameVistaPharm, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Providence, NJ 07974

Trademark Events

Event DateEvent Description
Monday, January 9, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 9, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 3, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, June 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 7, 2022SOU EXTENSION 2 GRANTED
Tuesday, June 7, 2022SOU EXTENSION 2 FILED
Tuesday, June 7, 2022TEAS EXTENSION RECEIVED
Wednesday, December 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 6, 2021SOU EXTENSION 1 GRANTED
Monday, December 6, 2021SOU EXTENSION 1 FILED
Monday, December 6, 2021TEAS EXTENSION RECEIVED
Tuesday, June 8, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 10, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 9, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 9, 2020NON-FINAL ACTION E-MAILED
Wednesday, September 9, 2020NON-FINAL ACTION WRITTEN
Friday, September 4, 2020ASSIGNED TO EXAMINER
Wednesday, June 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 6, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

runtanza thyroid hormone cancer deficiency hypothyroidism preparations treatment pharmaceutical